Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease

Background. Hypertension is a common complication in autosomal dominant polycystic kidney disease (ADPKD). This prospective randomized double-blind study was performed to compare the renal and cardiac effects of the ACE inhibitor ramipril and the β-blocker metoprolol as first line therapy in ADPKD p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2008-02, Vol.23 (2), p.573-579
Hauptverfasser:	Zeltner, Raoul, Poliak, Roudolf, Stiasny, Birgit, Schmieder, Roland E., Schulze, Bernd D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - pharmacology Adrenergic beta-Antagonists - therapeutic use Adult Angiotensin-Converting Enzyme Inhibitors - pharmacology Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use autosomal dominant polycystic kidney disease Blood Pressure - drug effects Double-Blind Method Female Follow-Up Studies Heart - drug effects Humans hypertension Hypertension - drug therapy Hypertension - etiology Kidney - drug effects left ventricular hypertrophy Male Metoprolol - pharmacology Metoprolol - therapeutic use Polycystic Kidney, Autosomal Dominant - complications progression of renal disease Prospective Studies Ramipril - pharmacology Ramipril - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!